How long can fatigue persist after discontinuing Latuda (lurasidone) 12 days ago?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Duration of Fatigue After Latuda Discontinuation

Fatigue after stopping Latuda 12 days ago may persist for several more weeks, as withdrawal symptoms from antipsychotics can extend beyond the acute withdrawal period, with some patients experiencing protracted symptoms for weeks to months after discontinuation.

Understanding the Timeline

The fatigue you're experiencing is likely part of a withdrawal syndrome from Latuda (lurasidone) discontinuation. While the FDA label for Latuda does not specifically detail withdrawal timelines 1, we can draw from general principles of antipsychotic discontinuation and drug withdrawal literature to understand what you're experiencing.

Acute vs. Protracted Withdrawal

Acute withdrawal symptoms from medications typically peak within 48-72 hours and resolve within 7-14 days 2. However, at 12 days post-discontinuation, you may be transitioning into or experiencing what's called protracted withdrawal syndrome.

Protracted withdrawal can include:

  • General malaise and fatigue
  • Decreased sense of well-being
  • Poor tolerance to stress
  • Dysphoria and irritability
  • Insomnia or sleep disturbances

These symptoms have been documented to persist for up to 6 months after medication discontinuation in some patients 2. The literature on opioid withdrawal specifically describes this secondary abstinence syndrome, but similar patterns occur with other centrally-acting medications including antipsychotics 3.

Why Fatigue Persists

Several factors contribute to prolonged fatigue after Latuda discontinuation:

  1. Pharmacokinetic factors: Lurasidone has an elimination half-life of approximately 18 hours 1. However, complete clearance and receptor readjustment takes considerably longer than simple drug elimination.

  2. Receptor adaptation: Your brain's dopamine and serotonin receptors need time to readjust after chronic blockade by Latuda. This neuroadaptation process extends well beyond drug clearance 1.

  3. Individual variability: Factors like your duration of Latuda use, dosage, metabolism, and individual physiology all influence recovery time.

What to Expect Moving Forward

Most patients experience gradual improvement over 2-8 weeks, though some symptoms may linger longer. The fatigue should progressively decrease in intensity rather than persist at the same level indefinitely.

Warning Signs Requiring Medical Attention

Contact your prescriber if you experience:

  • Worsening rather than improving fatigue
  • Severe functional impairment preventing daily activities
  • New psychiatric symptoms (mood changes, psychosis)
  • Physical symptoms suggesting other medical causes (fever, weight changes, pain)

Management Strategies

While waiting for natural resolution:

  • Maintain regular sleep-wake cycles to support circadian rhythm recovery
  • Gradual increase in physical activity as tolerated (even light walking can help)
  • Adequate nutrition and hydration
  • Avoid abrupt discontinuation of other medications without medical guidance
  • Monitor for other withdrawal symptoms like nausea, agitation, or movement disorders that were common during Latuda treatment 1

Important Caveats

The fatigue could also represent:

  • Unmasking of underlying condition: The original psychiatric condition that Latuda was treating may be contributing to fatigue
  • Concurrent medical issues: Rule out anemia, thyroid dysfunction, sleep disorders, or other medical causes
  • Medication interactions: If you're taking other medications, interactions or their side effects could contribute

If fatigue remains severe or functionally impairing beyond 4-6 weeks, reassessment by your prescriber is warranted to distinguish between protracted withdrawal and other causes requiring different interventions 3, 2.

References

Related Questions

When can I expect to return to baseline after stopping lurasidone (Latuda) 12 days ago?
When can I expect to feel better after discontinuing Latuda (lurasidone) for 12 days?
How long can brain fog persist after stopping lurasidone (Latuda) 40 mg, eight days ago?
How much longer can withdrawal symptoms persist after 20 days of stopping Latuda (lurasidone)?
After stopping Latuda (lurasidone) abruptly after 22 days, when can I expect my neurological function to return to normal?
In an infant with a diffuse erythematous maculopapular rash involving the extensor surfaces of the arms, elbows, and genital area, with 1‑3 mm macules and papules that have coalesced, mild irritation, and no bullae, erosions, or silvery scaling, what is the most likely diagnosis and what first‑line management is recommended?
What is the recommended tapering schedule for bupropion (Wellbutrin) and how should I initiate vortioxetine (Trintellix) in a 72-year-old patient who drinks alcohol daily?
In a 22‑year‑old woman with a history of migraine with aura since age 12 who presents with a prolonged morning headache refractory to rizatriptan, acetaminophen, and ibuprofen, and reports posterior neck tension, what differential diagnoses should be considered?
In a 6½‑year‑old thin girl with a family history of thinness who has fine pubic (vellus) hair, could this represent early adrenarche, or is it a normal finding?
In an 85-year-old woman with chronic heart failure, COPD, shortness of breath, severe chronic kidney disease (eGFR 16–28 mL/min), hyperkalemia (potassium 5.1–5.5 mmol/L), anemia with low transferrin saturation, secondary hyperparathyroidism, and markedly elevated NT‑proBNP, how should her volume status and guideline‑directed heart‑failure therapy be optimized?
What are the recommended fluvoxamine dosage guidelines for adults with obsessive‑compulsive disorder, children and adolescents, and patients with liver disease or the elderly?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.